1.97 USD
▼-0.02-1.01%
盘后 2.28 0.00%
2026-09-16
市值
$21.14M
市盈率
—
EPS
-3.71
股息率
—
52 周区间
1.65 – 3.07
成交量
9.47K
Beta
0.27
目标价
9.50
52W 低 1.6552W 高 3.07
价格走势
公司简介
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatm...